Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone furoate plus moisturizer for atopic dermatitis or non-wet eczema
ChiCTR-TRC-13003551Phase 4Completed
- Sponsor
- Institute of Dermatology, Chinese Academy of Medical Sciences
- Start
- Jan 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of mometasone in atopic dermatitis (AD) (2 arms), sponsored by Institute of Dermatology, Chinese Academy of Medical Sciences. Primary endpoints: Recurrence rate, Median time to recurrence and 2 more. Started Jan 2011; status: completed.
02
Drugs
mometasone
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on ChiCTR-TRC-13003551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003551.